Skip to contentN
Nutra Pharma Corp
N
NPHCNutra Pharma Corp Q1 2016 · 10-Q
Revenue$37.39K$37.39K−69.1% vs Q1 2015 Net Income-$1.07M-$1.07MN/M vs Q1 2015 EPS Diluted-$0.01-$0.01N/M vs Q1 2015 Gross Profit$29,913−68.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR
Operating Cash Flow-$265,734N/M Margins · derivedGross margin80.0%+0.7 pt vs Q1 2015
Operating margin-948.5%−706.5 pt vs Q1 2015
Net margin-2874.9%−2574.0 pt vs Q1 2015
ended Mar 31, 2016 · filed May 27, 2016 · 57 d after period end